Navigation Links
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
Date:10/7/2008

rmally increased intestinal permeability and the genesis of some autoimmune diseases, either as a result of reduction of antigen presentation to the body's immune system, or through inhibitory, direct effects on gastrointestinal associated lymphoid tissue. Larazotide acetate is a non-absorbed peptide which improves mucosal barrier function by inhibiting cytoskeletal reorganization and tight junction disassembly. Larazotide acetate is orally formulated, has been granted "Fast Track" designation by the U.S. Food and Drug Administration for the treatment of Celiac disease, and is also being evaluated for the treatment of Crohn's Disease. Results of the Company's first study in patients with celiac disease are available online at: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03413.x

For more information about Alba's clinical trials, please visit the http://www.clinicaltrials.gov web site and search for Alba Therapeutics.

About Alba Therapeutics Corporation

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat auto-immune, immune mediated and inflammatory diseases and is located in Baltimore, Maryland. Alba's technology platform is based upon a key pathway that regulates the assembly and disassembly of tight junctions in cell barriers throughout the body. As a result of its unique technology platform, Alba is a leader in mucosal biology and has developed a pipeline of innovative therapeutic candidates that has the potential to modify the course of disease and significantly improve upon existing treatments for a wide range of diseases such as Celiac disease, Crohn's disease, and Asthma/COPD or acute lung injury.

Media: Mariesa Kemble


'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
2. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
4. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
5. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
6. Data from In Vivo Disease Models on Taligen Therapeutics Pipeline Candidates to be Presented at the XXII International Complement Workshop
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
10. Tobira Therapeutics Inc. Receives US Patent for TBR-652
11. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... regular meeting of the board of directors of The ... declared a regular quarterly dividend of 31 cents per ... at the close of business on February 10, 2010. ... Lubrizol Corporation (NYSE: LZ ) is an ... that improve the quality and performance of our customers, ...
(Date:12/15/2009)... PALO ALTO, Calif., Dec. 15 Varian Medical ... it will report results for first quarter of fiscal ... Wednesday, January 27, 2010. The news release will ... parties at 2:00 p.m. PT. The news release ... be available on the company website at: www.varian.com/investor ...
(Date:12/15/2009)... DALLAS, Dec. 15 Estill Medical Technologies, Inc., ... Angel Blood and IV Fluid Infusion Warmer , a ... , military and emergency responders ... named the CALSTAR 6 Unit of South Lake Tahoe ... of the Year Award." ,, CALSTAR is ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4ERC provides millions for biodiversity research 10572 1ERC provides millions for biodiversity research 10572 2ERC provides millions for biodiversity research 10572 3UT Southwestern researchers use drug radiation combo to eradicate lung cancer 10567 1UT Southwestern researchers use drug radiation combo to eradicate lung cancer 10567 2November Marks Fifth Annual National Pet Cancer Awareness Month 60313 1November Marks Fifth Annual National Pet Cancer Awareness Month 60313 2November Marks Fifth Annual National Pet Cancer Awareness Month 60313 3
... on the ... Localized Prostate Cancer, TORONTO, Nov. 14 A Canadian ... - a Health Canada,approved treatment for localized prostate cancer - ... Can-Am HIFU, a prostate,cancer treatment centre, will conduct an REB/Health ...
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), reported ... announced the selection of its,disinfectant, EnviroTru(TM) for ... (Metro). EnviroTru(TM) is a multi-purpose disinfectant ... also meets EPA requirements for,Toxicity Category IV ...
Other Medicine Technology:Prostate Cancer Treatment Centre Receives Funding for Clinical Trials 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3
(Date:12/15/2009)... new study published by The University of Western Ontario ... and unpaid work report higher average measures of happiness ... , The ,shared roles, category, where each partner,s unpaid ... unpaid work, is a growing category that now represents ... more likely to be in a shared roles model ...
(Date:12/15/2009)... understand how to make an AIDS vaccine have found ... that the immune system can indeed produce cells with ... at the same time, the immune system works equally ... they have a chance to mature. , "These studies ... viral disease is under the control of immunological tolerance," ...
(Date:12/15/2009)... good-looking people really benefit from their looks, and in ... of Georgia and the University of Kansas found that ... relationships and therefore an increased sense of psychological well-being. ... we spend billions of dollars each year trying to ... month,s issue of Personal Relationships , also determines ...
(Date:12/15/2009)... Intelligence Agency has requested documents from an investigative journalist, even ... itself under the Freedom of Information Act. , ... ... a bizarre about-face, the secretive Central Intelligence Agency has requested ... earlier obtained them from the CIA itself under the Freedom ...
(Date:12/15/2009)... Design, a leading provider of Human Resource Management Systems (HRMS), ... solutions from its clients, Self Service Applicant (APSS) to its ... on strategic matters. , ... Mahwah, ... provider of Human Resource Management Systems (HRMS), announced in a ...
Breaking Medicine News(10 mins):Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:The importance of attractiveness depends on where you live 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Humanic Design is Pleased to Announce Application Self Service (APSS) to its Product Suite to Empower Organizations with Automation 2
... a substance derived from the bark of the South American ... ,The study, conducted at UT Southwestern Medical Center, has ... treatment for the most common type of lung cancer. ... and is presently being used in a clinical trial to ...
... conservatives-dominated US Supreme Court seems set to leave its mark, ... W. Bush. ,It said on Monday that that it ... medical equipment manufacturers approved by the federal government may be ... ,At the end of the case, the ...
... into the car and heading towards the highway. At times ... This means some passengers have a bout of car sickness ... happens when the eyes, inner ears and joints get conflicting ... is moving, says Chamberlain, a clinical instructor at Lucille Packard ...
... Researchers have successfully reversed the symptoms of mental retardation and ... ,The study was conducted by a team of researchers including ... for Learning and Memory at MIT. ,As part ... X Syndrome (FXS), the leading inherited cause of mental retardation ...
... heavy toll in England, both in terms of lives and ... according to a report published today by the All Party ... Wasted Money, Wasted Lives - concludes that, despite effective treatments, ... people are living with unnecessary seizures, and 74,000 people are ...
... reached a tentative agreement with Delmont Laboratory to introduce ... staphylococcal infection . According to this initial agreement, Delmont ... contract local manufactures for the final packaging in China. ... a definitive agreement is to be signed. This product ...
Other Medicine News:Health News:Tree Bark Substance may Hold New Lung-cancer Treatment 2Health News:US Supreme Court Could Protect Medical Equipment Manufacturers from Law Suits 2Health News:Car Sickness for the Little Ones can Be Prevented 2Health News:Car Sickness for the Little Ones can Be Prevented 3Health News:Researchers Reverse Mental Retardation Symptoms in Mice 2Health News:Blunders in Epilepsy Care Cost Lives, and Money UK Report 2
Pilot and control your analysis at a touch. 26 parameters CBC/DIFF with autoloader...
... System is an easy-to-use, workflow-based system designed to ... Inspirex consists of the SleepWorks software and either ... and durable systems can be used for a ... - including full EEG recording - and have ...
... PR 2100 is a compact, stand-alone microprocessor-controlled ... specimens in 96-well microplates using single- or ... (2.7-for dual-wavelength) and a dynamic reading range ... to meet any laboratory or assay requirements. ...
... The VARIANT II™ Total ... fast, totally-automated and objective ... of total glycated hemoglobin ... The results are reported ...
Medicine Products: